SciSparc (SPRC) Revenue (2016 - 2022)

SciSparc (SPRC) posted Revenue of $1.2 million for Q4 2022, up 120.93% sequentially from -$5.6 million in Q3 2022.

SciSparc (SPRC) Revenue (2016 - 2022) Analysis & Trends

SciSparc has reported Revenue for 4 years, with the latest figure at $1.2 million in Q4 2022.

Quarterly Revenue changed N/A year-over-year to $1.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $753000.0 (changed N/A YoY) and the FY2025 annual result came in at $856000.0, down 34.46% from the prior year.
Revenue rose to $1.2 million in Q4 2022 per SPRC's latest filing, from -$5.6 million in the prior quarter.
Over five years, Revenue peaked at $3.4 million in Q4 2018 and troughed at -$5.6 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	3.33 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	4.29 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	1.52 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	145.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	1.71 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	1.29 Bn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	425.49 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	674.14 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	1.06 Bn
10	SciSparc	836,385.99	836,385.99	-	-

Download Data